Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More
Xconomy
AUGUST 5, 2016
Then came the rumor mill: Companies may or may not be approaching Biogen about a sale, and Biogen may or may not be fielding offers. The rumors boosted Biogen’s sinking stock price nearly 10 percent. Published in January, the technology comes from the lab of Keith Joung, who is an Editas cofounder.
40 
Let's personalize your content